Flat corneas produce unpredictable visual outcomes after PRK

Article

Flat, steep corneas with keratometry values of less than 35 D do not have a predictive effect on the risk of visual acuity loss after myopic photorefractive keratectomy (PRK), claims a paper in the Journal of Refractive Surgery.

Flat, steep corneas with keratometry values of less than 35 D do not have a predictive effect on the risk of visual acuity loss after myopic photorefractive keratectomy (PRK), claims a paper in the Journal of Refractive Surgery.

Dr David Varssano et al., Tel-Aviv Medical Centre, Tel-Aviv, Israel, retrospectively analysed the visual acuity of 5410 eyes that underwent PRK from January 2006 to November 2010. All patients were assessed for the effect of postoperative corneal curvatures on visual outcomes. The main outcome measures were postoperative corrected distance visual acuity (CDVA) and loss of CDVA.

A worse postoperative CDVA was observed in corneas with a flat meridian of less than 35 D and those with a steep meridian of less than 35 D. The worst preoperative CDVA presented in the flatter curvatures in all comparisons conducted for the study. This indicates that calculated meridian curvature had no effect on CDVA loss.

Overall, the team discovered that postoperative corneal keratometry values, especially flat and steep meridians, of less than 35 D did not have a predictive effect on the risk of losing visual acuity after myopic PRK.

For the full abstract please click here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.